Now, M2M Pharma known in the industry as an "Agile Company" to develop your products at early stage by having air-jet milling-micronisation, planetary milling, spray drying (with an inert loop to handle organic solvent), freeze drying, rotary evaporation, turbula blender etc, as in-house techniques with decades of experience. Analytical techniques like NGI, HPLC are often used to measure APSD, emitted dose, content uniformity etc. for an early stage inhaled product development.
Amorphous Solid Dispersion (ASD) can now be made at M2M Pharma with its spray drying, rotary-evaporation and/or planetary ball milling techniques. Most importantly, the product under development is well supported by the material science capability and decades of knowledge and experience in this field that are essential for a successful product.
Copyright © 2024 M2M Pharmaceuticals Ltd - All Rights Reserved. Company Registration Number: 09976638
Powered by GoDaddy Website Builder